Project Details
| Short title | IMMU-132-11 |
|---|---|
| Acronym | IMMU-132-11 |
| Status | Active |
| Effective start/end date | 7/07/22 → 15/06/27 |
CTU A PHASE 2 OPEN-LABEL STUDY OF SACITUZUMAB GOVITECAN (IMMU-132) IN SUBJECTS WITH METASTATIC SOLID TUMORS
- Zhang, Alison (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Chester, Catherine (Clinical Trial Unit Staff)
Project: Research